1. When Will I See The Results From Tirzepatide?
There are a variety of factors that contribute to the results of Tirzepatide treatment. However, many patients begin seeing results around the twelve to sixteen-week mark. Patients who stick to healthier diets and lifestyles often see results faster than patients who do not.
2. How Much Does Tirzepatide Cost?
At Allure Esthetic, the compounded Tirzepatide has a monthly flat fee of $750. This includes the monthly prescription, all appointments, both in-person and virtual, and access 24/7 access to on-call doctors.
3.Are There Any Side-Effects From Tirzepatide?
The side effects of compounded Tirzepatide for weight loss are similar to those of semaglutide. However, most patients report that the side effects are less severe and often temporary as their body adjusts to the medication. Some side effects can include:
- Upset or queasy stomach
- Acid reflux
- Disruption in bowel movements
- Acute abdominal pain
- Swelling at the injection site
- Itching at the injection site
- Rare chance of labored breathing
- Rare chance of facial swelling
- Rare chance of an allergic reaction
4. Should I Take Semaglutide or Tirzepatide for Weight Loss?
Both Semaglutide and Tirzepatide medications greatly aid in weight loss. Whether one is better can depend on the patient’s personal records, genetics, and overarching goals. Dr. Sajan can help patients find the best Seattle weight-loss medication for them.
5. Do You Have To Take Tirzepatide Forever?
Tirzepatide is a long-term medicine; however, the patient’s goal is to build healthy habits and maintain them while continuing injections. Once they achieve their ideal weight, patients may be able to slowly come off the medication under the direction of Dr. Sajan or a provider at Allure Esthetic. Patients may need to continue a maintenance dose of Tirzepatide if they struggle to keep weight off without the medication.
6. How is it dosed?
Weekly subcutaneous injection with stepwise increases (e.g., 2.5 mg up to 15 mg as tolerated per label). (medical.lilly.com)
7. Any new indications?
Yes—FDA approved Zepbound to improve OSA in adults with obesity in 2024/2025. (investor.lilly.com)
8. Is there a pill?
No—tirzepatide is not available orally. (medical.lilly.com)
9. What about access/cost?
Lilly announced self‑pay single‑dose vials for all doses via LillyDirect in June 2025. (investor.lilly.com)